Clinical Trial Update: Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of phenylbutyrate and genistein in Delta F508 homozygous cystic fibrosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Genistein (genistein)
• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED